SCHEMBL7927216

SCHEMBL7927216

C=CCCCCOC(=O)NCC(=O)O

nearest known ligand 0.46

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ABCC4 O15439 1/20 0.46
MAPT P10636 1/20 0.46
EPHX2 P34913 2/20 0.44
HRH4 Q9H3N8 2/20 0.43
HRH3 Q9Y5N1 2/20 0.43
ACHE P22303 6/20 0.41
ALDH1A1 P00352 3/20 0.41
LPAR3 Q9UBY5 2/20 0.41
LMNA P02545 1/20 0.41
LPAR2 Q9HBW0 1/20 0.41
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16493952 0.98 ABCC4 (0.48) ABCC4MAPTEPHX2HRH4HRH3
SCHEMBL731156 0.96 ABCC4 (0.46) ABCC4MAPTEPHX2HRH4HRH3
SCHEMBL28289954 0.82 ACHE (0.49) EPHX2HRH4HRH3ACHEALDH1A1
SCHEMBL13331638 0.82 ACHE (0.58) EPHX2HRH4HRH3ACHEALDH1A1
SCHEMBL4680857 0.81 CASP1 (0.45) ABCC4MAPTCYP3A4
SCHEMBL11339356 0.81 ACHE (0.51) EPHX2ACHEALDH1A1LMNA
SCHEMBL22588787 0.79 ACHE (0.59) EPHX2HRH4HRH3ACHE
SCHEMBL11325903 0.78 ACHE (0.62) EPHX2ACHE
SCHEMBL8220165 0.78 GAA (0.47) EPHX2HRH4HRH3ACHEALDH1A1
SCHEMBL8849277 0.78 ACHE (0.61) EPHX2ACHELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1913016-B1 MACROCYCLIC PEPTIDES AS HCV NS3 PROTEASE INHIBITORS MERCK SHARP & DOHME (US) 2013-01-16 EP disclosed
EP-2178902-B1 MACROCYCLIC COMPOUNDS AS ANTIVIRAL AGENTS ANGELETTI P IST RICHERCHE BIO (IT) 2012-11-28 EP disclosed
WO-2010036551-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-04-01 WO disclosed
WO-2006119061-A2 HCV NS3 PROTEASE INHIBITORS MERCK & CO., INC. (US) 2006-11-09 WO disclosed